160 related articles for article (PubMed ID: 31757051)
1. Electrophysiology and Behavioral Assessment of the New Molecule SMe1EC2M3 as a Representative of the Future Class of Triple Reuptake Inhibitors.
Koprdova R; Csatlosova K; Durisova B; Bogi E; Majekova M; Dremencov E; Mach M
Molecules; 2019 Nov; 24(23):. PubMed ID: 31757051
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the electrophysiological properties of triple reuptake inhibitors on monoaminergic neurons.
Guiard BP; Chenu F; El Mansari M; Blier P
Int J Neuropsychopharmacol; 2011 Mar; 14(2):211-23. PubMed ID: 20149268
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo characterization of PA01, a novel promising triple reuptake inhibitor.
Hou J; Xing Y; Zuo D; Wu Y; Tian J; Meng Q; Yang M
Physiol Behav; 2015 Jan; 138():141-9. PubMed ID: 25447484
[TBL] [Abstract][Full Text] [Related]
4. Effect of a New Substance with Pyridoindole Structure on Adult Neurogenesis, Shape of Neurons, and Behavioral Outcomes in a Chronic Mild Stress Model in Rats.
Zvozilova A; Reichova A; Mach M; Bakos J; Koprdova R
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255918
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute and sustained administration of the catecholamine reuptake inhibitor nomifensine on the firing activity of monoaminergic neurons.
Katz NS; Guiard BP; El Mansari M; Blier P
J Psychopharmacol; 2010 Aug; 24(8):1223-35. PubMed ID: 19939862
[TBL] [Abstract][Full Text] [Related]
6. Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors.
Guiard BP; El Mansari M; Blier P
Curr Drug Targets; 2009 Nov; 10(11):1069-84. PubMed ID: 19702555
[TBL] [Abstract][Full Text] [Related]
7. Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties.
Tian JW; Jiang WL; Zhong Y; Meng Q; Gai Y; Zhu HB; Hou J; Xing Y; Li YX
Neuroscience; 2011 Nov; 196():124-30. PubMed ID: 21925241
[TBL] [Abstract][Full Text] [Related]
8. The antidepressant-like pharmacological profile of Yuanzhi-1, a novel serotonin, norepinephrine and dopamine reuptake inhibitor.
Jin ZL; Gao N; Li XR; Tang Y; Xiong J; Chen HX; Xue R; Li YF
Eur Neuropsychopharmacol; 2015 Apr; 25(4):544-56. PubMed ID: 25638027
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
Shaw AM; Boules M; Zhang Y; Williams K; Robinson J; Carlier PR; Richelson E
Eur J Pharmacol; 2007 Jan; 555(1):30-6. PubMed ID: 17109850
[TBL] [Abstract][Full Text] [Related]
10. Combined In Silico, Ex Vivo, and In Vivo Assessment of L-17, a Thiadiazine Derivative with Putative Neuro- and Cardioprotective and Antidepressant Effects.
Sarapultsev A; Vassiliev P; Grinchii D; Kiss A; Mach M; Osacka J; Balloova A; Paliokha R; Kochetkov A; Sidorova L; Sarapultsev P; Chupakhin O; Rantsev M; Spasov A; Dremencov E
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948423
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS).
Liang Y; Shaw AM; Boules M; Briody S; Robinson J; Oliveros A; Blazar E; Williams K; Zhang Y; Carlier PR; Richelson E
J Pharmacol Exp Ther; 2008 Nov; 327(2):573-83. PubMed ID: 18689611
[TBL] [Abstract][Full Text] [Related]
12. Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain.
El Mansari M; Ghanbari R; Janssen S; Blier P
Neuropharmacology; 2008 Dec; 55(7):1191-8. PubMed ID: 18708076
[TBL] [Abstract][Full Text] [Related]
13. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of brexpiprazole on serotonin, dopamine, and norepinephrine systems: an in vivo electrophysiologic characterization.
Oosterhof CA; El Mansari M; Blier P
J Pharmacol Exp Ther; 2014 Dec; 351(3):585-95. PubMed ID: 25225185
[TBL] [Abstract][Full Text] [Related]
15. The novel trisubstituted pyran derivative D-142 has triple monoamine reuptake inhibitory activity and exerts potent antidepressant-like activity in rodents.
Dutta AK; Gopishetty B; Gogoi S; Ali S; Zhen J; Reith M
Eur J Pharmacol; 2011 Dec; 671(1-3):39-44. PubMed ID: 21963455
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.
Carlier PR; Lo MM; Lo PC; Richelson E; Tatsumi M; Reynolds IJ; Sharma TA
Bioorg Med Chem Lett; 1998 Mar; 8(5):487-92. PubMed ID: 9871604
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of New Approaches to Depression Treatment Using an Animal Model of Pharmacoresistant Depression.
Zvozilova A; Bukatova S; Koprdova R; Mach M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791304
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.
Zheng YY; Guo L; Zhen XC; Li JQ
Eur J Med Chem; 2012 Aug; 54():123-36. PubMed ID: 22608762
[TBL] [Abstract][Full Text] [Related]
19. Further structure-activity relationship studies on 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: identification of compounds with triple uptake inhibitory activity as potential antidepressant agents.
Gopishetty B; Hazeldine S; Santra S; Johnson M; Modi G; Ali S; Zhen J; Reith M; Dutta A
J Med Chem; 2011 Apr; 54(8):2924-32. PubMed ID: 21446715
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor.
Skolnick P; Popik P; Janowsky A; Beer B; Lippa AS
Eur J Pharmacol; 2003 Feb; 461(2-3):99-104. PubMed ID: 12586204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]